Biliary Tract Neoplasms Completed Phase 2 Trials for Nivolumab (DB09035)

Also known as: Biliary Tract Neoplasm / Neoplasm biliary tract / Biliary neoplasm NOS / Biliary neoplasm / Neoplasm of biliary tract (disorder) / Biliary neoplasia

IndicationStatusPhase
DBCOND0032430 (Biliary Tract Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02829918Study of Nivolumab in Patients With Advanced Refractory Biliary Tract CancersTreatment
NCT03101566Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract CancerTreatment